The purpose of this symposium is to update medical practitioners in the greater Midwest region on the future of cardiac electrophysiology, and on new diagnosis and treatment guidelines in the care and management of patients with atrial and ventricular arrhythmias and heart failure. Participants will learn about advances in atrial fibrillation ablation techniques. A review of clinical trials that have helped change the clinical practice of EP will be held. Participants in this symposium will examine the latest trends in Left Atrial Appendage exclusion and gain a greater understanding of anticoagulation and stroke prophylaxis. An examination of arrhythmia and device therapies that affect congenital heart disease patients will be discussed.
The program will address the following learning objectives:
- Discuss types of devices used for monitoring and treating arrhythmias, including advances in ablative techniques.
- Demonstrate the use of imaging techniques to improve procedural outcomes.
- Apply guideline-endorsed, clinically applicable strategies to help resolve lead failure, device malfunctions, and other device-related issues.
- Summarize clinical trial results that can be applied to improving the safety and efficacy of electrophysiology (EP) procedures.
- Investigate the role that genetics has in patients with arrhythmias.
- Explain anticoagulation treatment and stroke prophylaxis options for cardiac patients.
- Examine clinical evidence for the latest trends in LAA treatments.
August 21-22, 2021
Overland Park Convention Center
Registration Coming Soon!